Grant: Master's Award: Canada Graduate Scholarships
McMaster University
$17,500.00
Discovering how age-associated increases in pro-inflammatory cytokines contribute to impaired macrophage function & increased susceptibility to disease.
FY 2013-14
Summary
Aging is accompanied by increased levels of protein mediators, known as cytokines, in serum and tissues, and observable changes in immune cell phenotype and function. This “inflammaging” is believed to contribute to a wide spectrum of diseases associated with aging (e.g. neurodegeneration, cardiovascular disease, and dementia) that share an inflammatory etiology, as well as an increased susceptibility to infectious disease (Franceshi et al., 2006).
Macrophages, which are white blood cells that reside in the tissue and play a critical role in the body’s first line of defense against infection, are believed to contribute to inflammaging to a greater extent than any other cell type. They are primarily responsible for phagocytosing, or engulfing, and digesting cellular debris and pathogens. Additionally, they recruit and activate other immune cells, through the secretion of cytokines and other protein mediators. Given that macrophages are involved in the pathology and/or resolution of virtually all age-associated diseases, there is surprisingly limited understanding of age-associated changes in macrophage function. I aim to characterize how microenvironmental changes in elderly individuals alter killing capacity and cytokine production in aged macrophages, and the mechanisms behind the impaired antibacterial function.
Although the general consensus is that changes in macrophage function are caused by constant exposure to elevated levels of pro-inflammatory cytokines, such as those associated with inflammaging, the data supporting this hypothesis remain sparse. Given that dysregulation of cytokine, tumor necrosis factor, or TNF, has been implicated in variety of age-associated human diseases, it has become a focus in our research. Previous work in our laboratory observed that macrophages from aged mice deficient in TNF, one of the primary mediators of age-associated inflammation, are functionally indistinguishable from those isolated from younger mice, suggesting that TNF plays a major role in contributing to the aged phenotype observed in macrophages. This aged phenotype consists of diminished bacterial killing and production of elevated levels of pro-inflammatory cytokines. I will assess the contribution of TNF to macrophage function through use of mouse models, in order to identify the cellular source of the cytokine, and whether it directly affects function.
Prior studies in our laboratory observed that macrophages from old mice have a delayed or reduced killing capacity, specifically against pneumococcal bacteria. Since, phagosome maturation, or the process by which internalized particles are destroyed following engulfment, is critical in macrophage-dependent clearance of pathogens, I will investigate whether major defects in phagosome maturation occur with age. Understanding which stages of macrophage killing are impaired will provide insight into why elderly individuals have an increased susceptibility to infection, and will subsequently assist in discovering why such impairment occurs.
As populations age, a better understanding of the processes associated with inflammaging and deteriorating cell function is essential to identify older people who are at risk of ageing-related chronic diseases, in order to facilitate successful, early, targeted interventions. Understanding the biological basis for impaired innate immunity associated with age is definitely a challenge. However, it has substantial clinical significance, as restoration or preservation of an efficient, refined immune response will lead to healthy aging and likely extended longevity due to reduced susceptibility to pathologies.
Reference:
Franceshi, C. et al. (2006). Inflammaging and anti-inflammaging, Mech Ageing Dev, 128(1): 92-105
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
311939
Name
Naidoo Aveshni
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Discovering how age-associated increases in pro-inflammatory cytokines contribute to impaired macrophage function & increased susceptibility to disease.
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Chronic Inflammation; Disease In Elderly; Disease Susceptibility; Immunosenescence; Inflammaging; Macrophages; Microbial Translocation; Myeloid Skewing; Pro-Inflammatory; Tumor Necrosis Factor Alpha
Abstract
Aging is accompanied by increased levels of protein mediators, known as cytokines, in serum and tissues, and observable changes in immune cell phenotype and function. This “inflammaging” is believed to contribute to a wide spectrum of diseases associated with aging (e.g. neurodegeneration, cardiovascular disease, and dementia) that share an inflammatory etiology, as well as an increased susceptibility to infectious disease (Franceshi et al., 2006).
Macrophages, which are white blood cells that reside in the tissue and play a critical role in the body’s first line of defense against infection, are believed to contribute to inflammaging to a greater extent than any other cell type. They are primarily responsible for phagocytosing, or engulfing, and digesting cellular debris and pathogens. Additionally, they recruit and activate other immune cells, through the secretion of cytokines and other protein mediators. Given that macrophages are involved in the pathology and/or resolution of virtually all age-associated diseases, there is surprisingly limited understanding of age-associated changes in macrophage function. I aim to characterize how microenvironmental changes in elderly individuals alter killing capacity and cytokine production in aged macrophages, and the mechanisms behind the impaired antibacterial function.
Although the general consensus is that changes in macrophage function are caused by constant exposure to elevated levels of pro-inflammatory cytokines, such as those associated with inflammaging, the data supporting this hypothesis remain sparse. Given that dysregulation of cytokine, tumor necrosis factor, or TNF, has been implicated in variety of age-associated human diseases, it has become a focus in our research. Previous work in our laboratory observed that macrophages from aged mice deficient in TNF, one of the primary mediators of age-associated inflammation, are functionally indistinguishable from those isolated from younger mice, suggesting that TNF plays a major role in contributing to the aged phenotype observed in macrophages. This aged phenotype consists of diminished bacterial killing and production of elevated levels of pro-inflammatory cytokines. I will assess the contribution of TNF to macrophage function through use of mouse models, in order to identify the cellular source of the cytokine, and whether it directly affects function.
Prior studies in our laboratory observed that macrophages from old mice have a delayed or reduced killing capacity, specifically against pneumococcal bacteria. Since, phagosome maturation, or the process by which internalized particles are destroyed following engulfment, is critical in macrophage-dependent clearance of pathogens, I will investigate whether major defects in phagosome maturation occur with age. Understanding which stages of macrophage killing are impaired will provide insight into why elderly individuals have an increased susceptibility to infection, and will subsequently assist in discovering why such impairment occurs.
As populations age, a better understanding of the processes associated with inflammaging and deteriorating cell function is essential to identify older people who are at risk of ageing-related chronic diseases, in order to facilitate successful, early, targeted interventions. Understanding the biological basis for impaired innate immunity associated with age is definitely a challenge. However, it has substantial clinical significance, as restoration or preservation of an efficient, refined immune response will lead to healthy aging and likely extended longevity due to reduced susceptibility to pathologies.
Reference:
Franceshi, C. et al. (2006). Inflammaging and anti-inflammaging, Mech Ageing Dev, 128(1): 92-105
Competitiondate
201312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Naidoo, Aveshni
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~